China Immunotech (beijing) Biotechnology Co., Ltd.
Clinical trials sponsored by China Immunotech (beijing) Biotechnology Co., Ltd., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New cell therapy aims to tame tough autoimmune diseases Results expected Nov 2026 (estimated)
- Experimental cell therapy targets autoimmune diseases that Won't quit Results expected Nov 2026 (estimated)
- New cell therapy offers hope for tough anemia cases Results expected Mar 2027 (estimated)